Fundies. English
ROCKWELL MEDICAL, INC.
EDGAR132 filing records in this dataset, filed from 1998-03-31 to 2026-08-13. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 10.5 million USD Source
Exact value
10519000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 3.97 million shares Source
Exact value
3972029 shares
Reported share-count change
15.36% · 529 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-13.
Financial data available through: 2025-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 8 of 11 periods available· newest 2025-12-31
- Net income: 8 of 11 periods available· newest 2025-12-31
- Operating cash flow: 8 of 11 periods available· newest 2025-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 8 of 11 periods available· newest 2025-12-31
- Total liabilities: 8 of 11 periods available· newest 2025-12-31
- Current assets: 8 of 11 periods available· newest 2025-12-31
- Current liabilities: 8 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 8 of 11 periods available· newest 2025-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 4.83 millionPrior period
−USD 480,000
–
Current period
−USD 5.31 million
–
Exact inputs and evidence
-5314000 − -480000 = -4834000 USD
-480000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-5314000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-116.7%Prior period
USD 4.2 million
–
Current period
−USD 700,000
–
Exact inputs and evidence
-700000 − 4202000 = -4902000 USD
4202000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-700000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2018-01-01 – 2018-12-31 | −USD 32.13 million Exact valueExact value: -32125858 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 20.42 million Exact valueExact value: -20419934 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 34.13 million Exact valueExact value: -34128000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 27.25 million Exact valueExact value: -27254000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 30.89 million Exact valueExact value: -30890000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 29.64 million Exact valueExact value: -29641000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2021 2021-01-01 – 2021-12-31 | −USD 32.67 million Exact valueExact value: -32674000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 33.53 million Exact valueExact value: -33534000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2022 2022-01-01 – 2022-12-31 | −USD 18.68 million Exact valueExact value: -18679000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 16.93 million Exact valueExact value: -16929000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 8.44 million Exact valueExact value: -8439000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.41 million Exact valueExact value: -9412000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 480,000 Exact valueExact value: -480000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.2 million Exact valueExact value: 4202000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 5.31 million Exact valueExact value: -5314000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 700,000 Exact valueExact value: -700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
132 filings · 4,195 latest values · 4,195 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001041024, 1041024, RMTI, edgar:1041024
Also known as ROCKWELL MEDICAL TECHNOLOGIES INC, ROCKWELL MEDICAL, INC., ROCKWELL MEDICAL, INC.